RYSE ran an investment programme in an exclusive partnership with DigitalHealth.London and MedCity in 2018, 2019, and 2020. We support companies that can grow across multiple markets, obtain a defensible market-leading position, and will deliver sustainable impact.
DigitalHealth.London is a collaborative programme delivered by MedCity and London’s three Academic Health Science Networks – UCL Partners, Imperial College Health Partners, and the Health Innovation Network. It is supported and sponsored by NHS England and the Mayor of London’s Office.
DigitalHealth.London Accelerator is a programme that aims to speed up the adoption of technology in London’s NHS, relieving high pressure on services and empowering patients to manage their health. Programme companies include Huma and Babylon Health.
RYSE invests in early stage companies (from Pre-Seed to Series B) to support them in their growth milestones. Companies are typically beginning to develop traction in the market and are looking to raise between £250,000 and £5,000,000.